Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

master pharm polska sp. z o.o. - kapsula

Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

rĪgas farmaceitiskĀ fabrika, as - šķidrums

Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

kapsula

Letonia - letón - Zāļu valsts aģentūra

novartis baltics, sia, latvia - ciklosporīns - kapsula, mīkstā - 100 mg

Letonia - letón - Zāļu valsts aģentūra

novartis baltics, sia, latvia - ciklosporīns - kapsula, mīkstā - 25 mg

Letonia - letón - Zāļu valsts aģentūra

novartis baltics, sia, latvia - ciklosporīns - kapsula, mīkstā - 50 mg

Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

boehringer ingelheim animal health france scs , francija - dzīvot infekcijas, bronhīts vīruss, celms h120 - putojošās tabletes suspensijas pagatavošanai - vistas

Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

boehringer ingelheim animal health france scs , francija - live newcastle disease virus, strain vg/ga-avinew - putojošās tabletes suspensijas pagatavošanai - vistas

Unión Europea - letón - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karcinoma, švamšā šūna - antineoplastiski līdzekļi - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Letonia - letón - Pārtikas un veterinārais dienests, Zemkopības ministrija

intervet international b.v., nīderlande - neomicīna sulfāts, prokaīna benzilpenicilīns - suspensija injekcijām - aitas; cūkas; kaķi; liellopi; suņi; zirgi